Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer
Clinical trial NCT03262948 · UNKNOWN
Trial details
- NCT number
- NCT03262948
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2019-10-01
- Enrollment
- 388
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.